Effect of Dapagliflozin on Insulin Secretion and Insulin Sensitivity in Patients With Prediabetes
Phase of Trial: Phase IV
Latest Information Update: 17 Jan 2018
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Prediabetic-state
- Focus Pharmacodynamics; Therapeutic Use
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association
- 01 May 2017 Status changed from active, no longer recruiting to completed.
- 25 Oct 2016 Status changed from recruiting to active, no longer recruiting.